Authorisation of antiviral medicines - guidance on the use of FP10SS forms and Antiviral Authorisation Vouchers during the H1N1 (swine flu) pandemic in England (24th September 2009)
This is a new guidance document on the use of Antiviral Authorisation Vouchers.
This guidance has been issued for two reasons:
This is a new guidance document on the use of Antiviral Authorisation Vouchers.
This guidance has been issued for two reasons:
- authorisation of antiviral medicines using Antiviral Authorisation Vouchers as well as specifically endorsed FP10SS forms has now been enabled.
- a change in the recommended dose for oseltamivir for children 6 months and over and up to 1 year of age from 2mg/kg to 3mg/kg has been announced by the European Commission.
Managing influenza-like illness (ILI) in nursing and residential homes during the current influenza pandemic (WHO Phase 6)
This guidance aims to provide advice on the generic management of cases or outbreaks of flu-like illness in nursing and residential homes, and provides specific guidance appropriate to pandemic (H1N1) 2009 influenza.
Guidance
This guidance aims to provide advice on the generic management of cases or outbreaks of flu-like illness in nursing and residential homes, and provides specific guidance appropriate to pandemic (H1N1) 2009 influenza.
Guidance
No comments:
Post a Comment